Insider Holders & Insider Ownership - IMMUNE PHARMACEUTICALS INC (IMNPQ)

List of insiders holdings for IMMUNE PHARMACEUTICALS INC:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Insider Holder NameReport
Date Time		Shares Owned
Directly
Indirectly		Total
Shares Owned		Filing
Teper Daniel Gedeon
CEO
10% Owner		2016-10-11 18:10:046,050,753
0		6,050,753Form 4
TVM III Limited Partnership
TVM Techno Venture Management No. III Limited Partnership
10% Owner		2007-02-14 15:22:304,559,328
0		4,559,328Form 13G
TVM IV GMBH & CO KG
TVM IV Management GmbH & Co. KG
10% Owner		2006-01-05 14:33:153,408,464
0		3,408,464Form 3
Merlin General Partner II LTD
Merlin Biosciences Fund L.P.
Merlin Biosciences Fund GbR
Member 13G Group - see Remarks
10% Owner		2006-01-04 17:25:120
2,461,928		2,461,928Form 3
Private Equity Direct Finance
10% Owner		2006-01-04 17:27:392,115,343
0		2,115,343Form 3
Kimball Ranch C
Director		2017-02-03 16:02:161,800,000
0		1,800,000Form 4
Luchi Monica E.
EVP & CMO		2016-08-04 21:41:50777,778
0		777,778Form 4
Kazado Daniel
Director		2017-01-27 19:13:06740,000
0		740,000Form 4
DUNTON ALAN W
Director		2013-08-14 17:38:30705,000
0		705,000Form 4
Paley Jeffrey
Director		2017-01-27 19:15:48700,000
0		700,000Form 4
Durrant Cameron
Director		2017-01-27 19:12:28690,000
0		690,000Form 4
Neczesny John A.
Director		2017-01-27 19:15:03640,000
0		640,000Form 4
Ben-Ami Miri
See Remarks		2016-06-03 16:53:58580,000
0		580,000Form 4
Savage Robert G.
Director		2013-08-14 17:50:02475,300
0		475,300Form 4
ALLARD STEPHANE
Chief Medical Officer		2012-12-28 15:37:21414,180
3333		417,513Form 4
Brownlie Keith L
Director		2013-08-14 17:45:39360,000
0		360,000Form 4
Tseng Ben
Chief Scientific Officer		2009-01-07 16:49:49329,291
0		329,291Form 4
Militello John
See Remarks		2016-06-03 16:06:24320,000
0		320,000Form 4
Talley John V.
President, CEO and Director		2011-01-19 17:10:19300,000
0		300,000Form 4
Chen Michael
VP-Global Business Development		2009-02-24 20:19:30263,560
0		263,560Form 4
Bedard John F.
Director		2008-07-02 10:14:17249,562
0		249,562Form 4
Maza Elliot M
Interim CEO		2017-07-20 20:52:25162,000
0		162,000Form 4
BHAGWAT DILEEP
Senior VP - Pharma. Devel.		2011-01-19 17:20:15100,000
0		100,000Form 4
Damask Michael C
Chief Medical Officer		2006-07-27 12:40:54100,000
0		100,000Form 3
Cook Robert W.
CFO and Senior VP		2014-02-05 12:36:08100,000
0		100,000Form 4
Berdugo Gad
CFO & SVP		2015-05-12 17:17:30100,000
0		100,000Form 4
SIDRANSKY DAVID
Director		2015-01-12 17:16:3671,699
0		71,699Form 4
De Kergrohen Herve
Director		2013-08-27 17:33:0671,419
0		71,419Form 4
Smyth A. Collier
Director		2012-06-25 11:11:5460,000
0		60,000Form 4
Yetter Wayne P.
Director		2012-06-25 11:19:2660,000
0		60,000Form 4
Waldheim Gerhard
Director		2012-06-25 11:15:4460,000
0		60,000Form 4
Stancic Ana
Director		2015-01-12 17:10:4650,000
0		50,000Form 4
LERER RENE
Director		2015-01-12 17:08:5150,000
0		50,000Form 4
AZRIA RENE PIERRE
Director		2015-09-16 17:17:5650,000
0		50,000Form 4
Jackson Guy C.
Director		2010-06-07 14:30:5835,000
0		35,000Form 4
Albouy Pierre
Director		2013-08-27 17:23:1029,758
0		29,758Form 4
Lockhart Earle
VP - Clinical & Reg Affairs		2006-01-09 16:15:0128,125
0		28,125Form 4
Elefant Dov
Controller - VP - Fin & Admin		2006-01-09 16:13:1528,125
0		28,125Form 4
Wiedemann Oliver
see remarks		2011-01-12 18:28:1225,000
0		25,000Form 4
McClurg Michael
VP - Bus Dvlpmnt - Oncology		2006-01-10 12:25:4320,000
0		20,000Form 4
Clark John P
See Remarks		2018-11-20 09:57:1120,000
0		20,000Form 3
Tyrrell Bernard R
Senior VP - Sales & Marketing		2010-02-12 18:42:2912,500
0		12,500Form 4
Kobrin Isaac
Director		2014-06-25 16:10:552400
0		2400Form 4
Caspritz Gert
Director		2008-10-08 11:59:290
0		0Form 5
Fiorino Anthony S.
Director		2020-02-04 11:45:530
0		0Form 4